Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema

Friday, April 8, 2011 1 min read

Key Takeaway: Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema

Full Press Release Details

Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema.